TerrAscend Corp.

TSND

CA88105E1088

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-06-21 pm EDT			5-day change	1st Jan Change
1.91 ^CAD	-2.05%		+3.24%	-13.18%

Jun. 17	Transcript : TerrAscend Corp. - Shareholder/Analyst Call
Jun. 10	Terrascend Corp. Announces Opening of the Apothecarium Nottingham, Maryland	CI

TerrAscend Corp. Provides Earnings Guidance for the Year 2023

August 10, 2023 at 04:10 pm EDT

TerrAscend Corp. provided earnings guidance for the year 2023. The Company is reiterating its outlook for Net Revenue from continuing operations for 2023 to be at least $305 million representing year-over-year growth of 23% in Net Revenue from continuing operations.

Latest news about TerrAscend Corp.

Transcript : TerrAscend Corp. - Shareholder/Analyst Call	Jun. 17
Terrascend Corp. Announces Opening of the Apothecarium Nottingham, Maryland	Jun. 10	CI
TerrAscend Corp. Opens Its New Detroit Dispensary, Gage 313	May. 29	CI
Transcript : TerrAscend Corp., Q1 2024 Earnings Call, May 09, 2024	May. 09
TerrAscend Brief: Q1 Net Revenue of US$80.6 million, an increase of 16.1% year-over-year; Cash Flow from operations of $13.3 million and Free Cash Flow of $10.5 million in the quarter	May. 09	MT
Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M	May. 09	MT
TerrAscend Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey	Apr. 24	CI
Transcript : TerrAscend Corp., 2023 Earnings Call, Mar 14, 2024	Mar. 14
TerrAscend Fourth-Quarter Loss Widens as Sales Rise by 26%	Mar. 14	MT
TerrAscend Brief: Q4 Net loss from continuing operations US$41.8 Million	Mar. 14	MT
TerrAscend Brief: Q4 Net Revenue was US$86.6 million, an increase of 25.5% year-over-year	Mar. 14	MT
TerrAscend Corp. Reports Impairment Charges for the Three Months Ended December 31, 2023	Mar. 14	CI
TerrAscend Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
North American Morning Briefing : Stock Futures Rise Ahead of PPI Data	Mar. 14	DJ
TerrAscend Corp. acquired the remaining 50.1% stake in Three Apothecarium dispensaries in California for $3.7 million.	Mar. 13	CI
TerrAscend Announcing Expansion of its Valhalla Product Offering	Jan. 24	MT
TerrAscend Brief: Announcing expansion of its Valhalla product offering	Jan. 24	MT
TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone State	Jan. 24	CI
Transcript : TerrAscend Corp., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
TerrAscend Corp. Raises Earnings Guidance for 2023	Nov. 09	CI
Earnings Flash (TSND) TERRASCEND Reports Q3 Net Revenue $89.2M	Nov. 09	MT
Earnings Flash (TSND) TERRASCEND Posts Q3 Revenue $89.2M	Nov. 09	MT
TerrAscend Brief: Raising Full Year 2023 Guidance	Nov. 09	MT
TerrAscend Brief: Q3 Net Revenue of US$89.2 million, an increase of 34.7% year-over-year and 23.7% sequentially	Nov. 09	MT

Chart TerrAscend Corp.

Duration

Period

More charts

Company Profile

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. It also operates Peninsula Alternative Health, a medical dispensary in Maryland. The Company owns or licenses several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. Ilera Healthcare is a medical cannabis cultivator, processor and dispenser with operations in New Jersey. Valhalla Confections is a manufacturer of cannabis-infused edibles.

Sector

Drug Retailers

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for TerrAscend Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.393 USD

Average target price

3.315 USD

Spread / Average Target

+137.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cannabis Product Retailers

	1st Jan change	Capi.
TERRASCEND CORP.	-13.18%	406M
GREEN THUMB INDUSTRIES INC.	+10.15%	2.83B
VERANO HOLDINGS CORP.	-19.22%	1.2B
HIGH TIDE INC.	+49.30%	187M
CANTOURAGE GROUP SE	-3.20%	92.59M
MARIMED INC.	-30.86%	72.26M
NOVA CANNABIS INC.	+41.57%	57.04M

Cannabis Product Retailers

TerrAscend Corp.

Equities

TSND

CA88105E1088

Drug Retailers

TerrAscend Corp. Provides Earnings Guidance for the Year 2023

EPS Revisions